StimGuide – the Gamechanger
We recently spoke with Dr Brian Forsythe, of Dallas Psychiatry TMS Clinic, to find out about the positive impact that StimGuide has had on his practice and patients.
August 12, 2020
Magstim has been awarded FDA 510K and UKCA approval for Horizon 3.0 with StimGuide+ which now includes indications for the treatment of adult patients with Treatment-Resistant (TRD) Major Depression Disorder (MDD), Anxiety Symptoms, and co-morbid Obsessive Compulsive Disorder (OCD). The Horizon 3.0 was designed specifically for the clinical setting.
Our team would like to thank all the TMS clinicians and treaters who provide life-changing TMS treatments safely to their patients. We recognize your dedication and we are here to support you every step of the way. As always, we are available if you have questions on how to operate the TMS system safely or to assist you on answering concerns your patients may have.
"We are here to support you every step of the way."
Magstim EGI is continuing to develop solutions that will provide greater access for patients who need TMS therapy. Our FDA-cleared 3-minute treatment allows practitioners to reduce exposure and treat more patients within the safety guidelines. Additionally, our StimGuide clinical navigation system enables both novice and expert treaters to effectively administer TMS consistently to a precise location – allowing practices to potentially treat more patients during this increased demand.
Thank you for your trust and partnership.
We recently spoke with Dr Brian Forsythe, of Dallas Psychiatry TMS Clinic, to find out about the positive impact that StimGuide has had on his practice and patients.
The first two sessions of our Magstim Academy lecture series have been a resounding success with several hundred registrants joining us from across the globe. We are now looking forward
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the
We recently spoke with Dr Brian Forsythe, of Dallas Psychiatry TMS Clinic, to find out about the positive impact that StimGuide has had on his practice and patients.
The first two sessions of our Magstim Academy lecture series have been a resounding success with several hundred registrants joining us from across the globe. We are now looking forward
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the